<bill session="116" type="h" number="6386" updated="2022-02-08T23:17:25Z">
  <state datetime="2020-03-25">REFERRED</state>
  <status>
    <introduced datetime="2020-03-25"/>
  </status>
  <introduced datetime="2020-03-25"/>
  <titles>
    <title type="display">No CHINA Act</title>
    <title type="official" as="introduced">To restrict the use of funds made available in appropriations Acts for fiscal year 2020 for the benefit of any United States or foreign person subject to the control of the People's Republic of China.</title>
    <title type="short" as="introduced">No CHINA Act</title>
    <title type="short" as="introduced">No Chinese Handouts In National Assistance Act</title>
  </titles>
  <sponsor bioguide_id="G000578"/>
  <cosponsors>
    <cosponsor bioguide_id="P000599" joined="2020-05-08"/>
    <cosponsor bioguide_id="Y000065" joined="2020-04-10"/>
  </cosponsors>
  <actions>
    <action datetime="2020-03-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-03-25" state="REFERRED">
      <text>Referred to the House Committee on Foreign Affairs.</text>
    </action>
    <action datetime="2020-04-03">
      <text>Referred to the Subcommittee on Asia, the Pacific and Nonproliferation.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSFA" name="House Foreign Affairs" subcommittee="" activity="Referral"/>
    <committee code="HSFA05" name="House Foreign Affairs" subcommittee="Indo-Pacific" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="International affairs"/>
    <term name="Appropriations"/>
    <term name="Asia"/>
    <term name="China"/>
    <term name="Executive agency funding and structure"/>
    <term name="Military procurement, research, weapons development"/>
    <term name="Public contracts and procurement"/>
  </subjects>
  <amendments/>
  <summary date="2020-08-18T21:39:49Z" status="Introduced in House">No Chinese Handouts In National Assistance Act or No CHINA Act

This bill generally prohibits funds made available during FY2020 from being expended for the benefit of any U.S. or foreign individual or entity subject to control by China's government. This restriction shall not apply to Taiwan or any Taiwanese entities. (China considers Taiwan a province of China.)

The President may also waive this restriction for U.S. national security interests.</summary>
</bill>
